COOPER JOHN G 4

What Happened

• John G. Cooper, a director of Rockwell Medical, received a grant (transaction code A) of 9,633 restricted stock units (RSUs) on July 1, 2026. The grant is shown at $0.00 per share (no cash paid at grant). The RSUs vest on July 1, 2027, subject to Cooper’s continued service through the 2027 Annual Meeting.

Key Details

• Transaction date: 2026-07-01; Form 4 filed: 2026-07-06.
• Shares granted: 9,633 RSUs; reported price: $0.00 per share.
• Vesting condition: July 1, 2027, contingent on continued service through the 2027 Annual Meeting (footnote F1).
• Reverse split note: A 1-for-10 reverse split took effect 12:01 AM on July 1, 2026; outstanding awards and reported share counts were proportionally adjusted (footnote F2).
• Shares owned after transaction: not specified in the provided excerpt (the filing indicates adjusted holdings post-reverse split).
• Filing timeliness: the filing date (July 6) is shown for the July 1 transaction; the excerpt does not explicitly flag a late filing.

Context

• RSU grants are common director compensation and do not reflect an immediate market purchase or sale. They only convert to shares (and potentially become sells) if/when they vest and are delivered. The reverse split reduced reported share counts and adjusted awards proportionally — review the company’s SEC filings for pre-split figures or further detail.